Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

25.45
+0.70002.83%
Pre-market: 26.941.49+5.85%04:59 EDT
Volume:296.73K
Turnover:7.49M
Market Cap:699.90M
PE:-9.47
High:25.77
Open:25.17
Low:24.78
Close:24.75
Loading ...

OnKure Therapeutics price target lowered to $30 from $35 at Oppenheimer

TIPRANKS
·
11 Mar

OnKure Therapeutics reports Q4 EPS ($1.37), consensus (86c)

TIPRANKS
·
11 Mar

Prescient Therapeutics Announces New Board Chair Amidst Growth Phase

TIPRANKS
·
11 Mar

Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges

TIPRANKS
·
11 Mar

Promising Clinical Developments and Strategic Advancements Support Buy Rating for Tenaya Therapeutics

TIPRANKS
·
11 Mar

Mineralys Therapeutics Launches $250 Million Public Offering of Shares

MT Newswires Live
·
11 Mar

Tenaya Therapeutics reports Q4 EPS (28c), consensus (31c)

TIPRANKS
·
11 Mar

Press Release: OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Dow Jones
·
11 Mar

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Business Wire
·
11 Mar

Press Release: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
11 Mar

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
11 Mar

Beam Therapeutics Raised to Sector Outperform From Sector Perform by Scotiabank

Dow Jones
·
11 Mar

Checkpoint Therapeutics Cut to Hold From Buy by Lake Street

Dow Jones
·
11 Mar

Beam Therapeutics Raised to Buy From Hold by Jones Trading

Dow Jones
·
11 Mar

Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate

Benzinga
·
11 Mar

JonesResearch upgrades Beam Therapeutics to Buy on de-risking data

TIPRANKS
·
11 Mar